RESECTABLE OSTEOSARCOMA

Clinical trials for RESECTABLE OSTEOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new RESECTABLE OSTEOSARCOMA trials appear

Sign up with your email to follow new studies for RESECTABLE OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New Two-Drug attack tested for tough childhood cancers

Disease control Completed

This early-phase study tested the safety and best dose of two antibody drugs, magrolimab and dinutuximab, given together to children and young adults whose neuroblastoma or osteosarcoma had come back or stopped responding to other treatments. The main goal was to see if the combi…

Matched conditions: RESECTABLE OSTEOSARCOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 12, 2026 13:51 UTC

RESECTABLE OSTEOSARCOMA

Get alerted when new RESECTABLE OSTEOSARCOMA trials appear

New Two-Drug attack tested for tough childhood cancers